Veracyte reported $39.96M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Agenus AGEN:US $ 18.91M 39K
Agilent A:US $ 386M 31M
Anika Therapeutics ANIK:US $ 21.27M 2.07M
Arrowhead Research ARWR:US $ 32.74M 1.12M
Biocept BIOC:US $ 10.47M 5.22M
Bruker BRKR:US $ 152.2M 6.1M
Exact Sciences EXAS:US $ 397.59M 4.36M
Heron Therapeutics HRTX:US $ 32.12M 836K
Illumina ILMN:US $ 410M 102M
Immunogen IMGN:US $ 23.79M 7.14M
Intrexon XON:US $ 12.67M 6.91M
Karyopharm Therapeutics KPTI:US $ 37.34M 1.43M
Laboratory Of America LH:US $ 486M 21.9M
Ligand Pharmaceuticals LGND:US $ 29.17M 10.99M
Rigel Pharmaceuticals RIGL:US $ 26.98M 420K
Sangamo Biosciences SGMO:US $ 15.09M 185K
Siemens SIE:GR 3.08B 148M
Sonic Healthcare SHL:AU $ 2.07B 70.56M
Thermo Fisher Scientific TMO:US $ 1.74B 537M
Veracyte VCYT:US $ 39.96M 4.18M
Waters WAT:US $ 161.88M 4.4M